Clik here to view.
Cold Genesys Secures Series B Investment for Pivotal and Combo Immunotherapy...
SANTA ANA, Calif. Cold Genesys Inc., a clinical-stage oncolytic immunotherapy company, today announced the successful completion of a Series B financing co-led by Ally Bridge Group and WI Harper...
View ArticleClik here to view.
GenomiCare Partners with N-of-One to Provide High-quality Clinical...
LEXINGTON, Mass. & SHANGHAI N-of-One, Inc., the global leader in clinical interpretation for precision medicine in oncology, and GenomiCare Biotechnology, a fast-growing precision medicine...
View ArticleClik here to view.
Sosei Subsidiary Heptares and AstraZeneca Enter Agreement to Develop Novel...
TOKYO Sosei Group Corporation (TOKYO:4565) is pleased to announce that its wholly-owned subsidiary Heptares Therapeutics (“Heptares”) and AstraZeneca have entered into a licensing agreement under...
View ArticleClik here to view.
Dr. Reddy’s Announces Strategic Collaboration with Amgen in India
HYDERABAD, India Dr. Reddy’s Laboratories Ltd. (NYSE: RDY) today announced that it has entered into a strategic collaboration with Amgen – one of the world’s leading independent biotechnology...
View ArticleClik here to view.
チルターンがセオレム・クリニカル・リサーチの買収契約を発表
ロンドン & 米ノースカロライナ州ウィルミントン （ビジネスワイヤ） — 世界的大手医薬品開発業務受託機関（CRO）のチルターンは、別の世界的大手CROのセオレム・クリニカル・リサーチを買収する契約を締結したと発表しました。 チルターン最高経営責任者（CEO）のJim...
View ArticleClik here to view.
Chiltern宣布同意收购Theorem Clinical Research
伦敦和北卡罗莱纳州威尔明顿 (美国商业资讯)–领先的全球性合同研究组织(CRO) Chiltern宣布已签署一份收购协议，收购另一家领先的全球性CRO Theorem Clinical Research。 Chiltern首席执行官Jim...
View ArticleClik here to view.
Chiltern Announces Agreement to Acquire Theorem Clinical Research
LONDON & WILMINGTON, N.C. Chiltern, a leading global contract research organization (CRO), announced it has signed a purchase agreement to acquire Theorem Clinical Research, another leading...
View ArticleClik here to view.
Cold Genesys的枢纽性和联合免疫疗法试验获得B轮投资
加州圣安娜 (美国商业资讯)–临床阶段溶瘤免疫疗法公司Cold Genesys Inc.今天宣布成功完成一笔B轮融资，该融资由Ally Bridge集团和WI Harper集团共同主导，Whitesun Healthcare Ventures和Song Hong Fang也参与其中。该笔内部人士发起的B轮融资为1000万美元，将用于推动Cold...
View ArticleClik here to view.
Clik here to view.
Extension Study Data Supporting Long-Term Safety and Efficacy of Eloctate®...
CAMBRIDGE, Mass. & STOCKHOLM Newly published clinical data demonstrate that people on extended-interval prophylaxis regimens with ELOCTATE® [Antihemophilic Factor (Recombinant), Fc Fusion...
View ArticleClik here to view.
FortuneRock (China) Co., Ltd. Announces Initial Public Offering (IPO) on...
BEIJING FortuneRock (China) Co., Ltd., a biotechnology and biopharmaceutical company, announced that it has received approval for its initial public offering and listing on the National Equities...
View ArticleClik here to view.
Macrogen Launches Special Promotion on Exome Sequencing
SEOUL, South Korea The precision medicine biotech company Macrogen (CEO Chong Hyon-yong, www.macrogen.com) (KOSDAQ:038290), announced on August 10th that it is launching a special promotion on exome...
View ArticleClik here to view.
Asterand Bioscience Acquires AdeptBio LLC
DETROIT Asterand Bioscience, Inc. is pleased to announce the acquisition of AdeptBio LLC, a Memphis-based biobank organization, which specializes in procurement of human tissue specimens. “We are...
View ArticleClik here to view.
Dr. Reddy’s Announces the Launch of PRAMIPEXOLE Dihydrochloride...
HYDERABAD, India Dr. Reddy’s Laboratories (NYSE: RDY) announced today that it has launched PRAMIPEXOLE dihydrochloride extended-release tablets 0.375 mg, 0.75 mg, 1.5 mg, 3 mg and 4.5 mg, a...
View ArticleClik here to view.
Arcadia Biosciences公布2015年第二季度及上半年财务业绩和业务摘要
加州戴维斯 (美国商业资讯)–农业科技公司Arcadia Biosciences, Inc. (NASDAQ: RKDA)今日公布了其2015年第二季度及上半年财务及业务结果。Arcadia的研发中产品涉及产品50余种，致力于通过控制植物的非生物逆境帮助农民朋友实现增产。...
View ArticleClik here to view.
チルターンがセオレム・クリニカル・リサーチの買収契約を発表
ロンドン & 米ノースカロライナ州ウィルミントン （ビジネスワイヤ） — 世界的大手医薬品開発業務受託機関（CRO）のチルターンは、別の世界的大手CROのセオレム・クリニカル・リサーチを買収する契約を締結したと発表しました。 チルターン最高経営責任者（CEO）のJim...
View ArticleClik here to view.
Chiltern宣布同意收购Theorem Clinical Research
伦敦和北卡罗莱纳州威尔明顿 (美国商业资讯)–领先的全球性合同研究组织(CRO) Chiltern宣布已签署一份收购协议，收购另一家领先的全球性CRO Theorem Clinical Research。 Chiltern首席执行官Jim...
View ArticleClik here to view.
Vantage mHealthcare Announces Banking Agreement with China Merchants Bank
NEW YORK Vantage mHealthcare, Inc. (OTCQB:VNTH) (“Vantage Health” or the “Company”) today announced that Nanobeak LLC, its parent company, has engaged China Merchants Bank New York for a private...
View ArticleClik here to view.
AmpliPhi Biosciences Announces Approval of Common Stock Listing on NYSE MKT
SAN DIEGO & RICHMOND, Va. & LJUBLJANA, Slovenia, & SYDNEY AmpliPhi Biosciences Corporation (OTCQB:APHBD), a global leader in developing bacteriophage-based antibacterial therapies to...
View ArticleClik here to view.
Vantage mHealthcare宣布与中国招商银行达成银行服务协议
纽约 (美国商业资讯)–Vantage mHealthcare, Inc. (OTCQB:VNTH)（下称“Vantage Health”或“公司”）今天宣布，其母公司Nanobeak LLC已与中国招商银行纽约分行达成了发行2000万美元私募股权的中国独家服务协议。...
View Article